Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Ataxia - paediatric

Gene: RFXANK

Amber List (moderate evidence)

RFXANK (regulatory factor X associated ankyrin containing protein)
EnsemblGeneIds (GRCh38): ENSG00000064490
EnsemblGeneIds (GRCh37): ENSG00000064490
OMIM: 603200, Gene2Phenotype
RFXANK is in 6 panels

2 reviews

Elena Savva (Victorian Clinical Genetics Services)

I don't know

PMID: 33855173 - 1 family (2 affecteds, 3rd not sequenced) with a homozygous c.271+1G>C splice variant, late-onset immunodeficiency and subacute progressive neurodegenerative disease, including cognition, motor, visual and cerebellar features. MRI demonstrated global cerebral and cerebellar atrophy.

PMID: 23314770 - 1/34 MHCII deficient patients with biallelic variants reported with ataxia. Majority of patients (including patient with ataxia) share a founder variant (c.338-25_338del26).

PMID: 28676232 - single 30 month old patient with ataxic gait and dysarthria and a homozygous PTC.

Summary: 3 patients but uncommon feature, variable expressivity
Sources: Literature
Created: 4 Oct 2021, 4:42 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Progressive Ataxia and Neurologic Regression; MHC class II deficiency, complementation group B MIM#209920

Publications

Danielle Ariti (University of Melbourne)

Green List (high evidence)

7 different RFXANK variants have been reported in 26 unrelated individuals; two mouse models

Homozygous and compound heterozygous variants (deletion, missense, nonsense or splice-site) reported.
The most frequent variant is a 26-bp deletion (752delG-25) which was reported in 21 individuals
* Founder effect for this deletion variant has been demonstrated (North African origin)

In all cases, the clinical presentation included early onset recurrent infections, severe diarrhoea and failure to thrive.
Created: 10 Aug 2021, 6:02 a.m. | Last Modified: 10 Aug 2021, 6:02 a.m.
Panel Version: 0.8713

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
MHC class II deficiency, complementation group B MIM# 209920; Bare Lymphocyte Syndrome, type II, complementation group B; Low CD4+ T cells; reduced MHC II expression on lymphocytes; Normal-low Ig levels; Failure to thrive; respiratory/gastrointestinal infections; liver/biliary tract disease; diarrhoea; Severe autoimmune cytopaenia; agammaglobulinaemia

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Literature
Phenotypes
  • Progressive Ataxia and Neurologic Regression
  • MHC class II deficiency, complementation group B MIM#209920
OMIM
603200
Clinvar variants
Variants in RFXANK
Penetrance
None
Publications
Panels with this gene

History Filter Activity

4 Oct 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: rfxank has been classified as Amber List (Moderate Evidence).

4 Oct 2021, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: rfxank has been classified as Amber List (Moderate Evidence).

4 Oct 2021, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Elena Savva (Victorian Clinical Genetics Services)

gene: RFXANK was added gene: RFXANK was added to Ataxia - paediatric. Sources: Literature Mode of inheritance for gene: RFXANK was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: RFXANK were set to PMID: 33855173; 23314770; 28676232 Phenotypes for gene: RFXANK were set to Progressive Ataxia and Neurologic Regression; MHC class II deficiency, complementation group B MIM#209920 Review for gene: RFXANK was set to AMBER